Search

Oral Cancer

D008

POST-THYROIDECTOMY PTH TESTING AND MISSED OPPORTUNITIES IN PREVENTING HYPOCALCEMIA: ARE WE FAILING THE TEST?

Endocrine

Aru Panwar, MD, FACS1, Robert Lindau, MD, FACS1, Harlan Sayles, MS2, Andrew Coughlin, MD, FACS1, Daniel Lydiatt, MD, DDS, FACS1, Oleg Militsakh, MD, FACS1, Angela Osmolak, MD1, Wiliiam Lydiatt, MD, FACS1

1Methodist Estabrook Cancer Center, Nebraska Methodist Hospital, Omaha, Nebraska, 2College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska


D009

NORMOCALCEMIC PRIMARY HYPERPARATHYROIDISM: A SYSTEMATIC REVIEW AND META-ANALYSIS ON LABORATORY VALUES

Endocrine

Blake R Hollowoa, MD, Horace J Spencer, MS, Brendan, Jr. C Stack, MD, FACS, FACE

University of Arkansas for Medical Sciences


D010

THE EFFECT OF IV ACETAMINOPHEN ON PAIN CONTROL IN THYROID AND PARATHYROID SURGERY

Endocrine

Mueez Qureshi, MD1, Catherine Lumley, MD2, Bruce Davidson, MD, FACS1

1Georgetown University Hospital, 2University of North Carolina Chapel Hill


D011

RETROAURICULAR THYROIDECTOMY WITH A NEXT-GENERATION SINGLE-PORT ROBOTIC SURGERY SYSTEM: PRECLINICAL STUDIES AND FIRST IN HUMAN CASE

Endocrine

Tyler Okland, MD1, Myung-Chul Lee, MD2, Kenric Tam, MD3, Estelle Chang, MD4, Eun Chang Choi, MD5, Floyd Christopher Holsinger, MD1, Yoon Woo Koh, MD5

1Stanford University, 2Korea Cancer Center Hospital, 3University of California -- Los Angeles School of Medicine, 4University of Nebraska, 5Yonsei University


D012

THYROID LOBECTOMY PROVIDES IMPROVED VALUE OVER TOTAL THYROIDECTOMY IN WELL-SELECTED PATIENTS WITH INTERMEDIATE RISK DIFFERENTIATED THYROID CARCINOMA

Endocrine

Olivia Do, MS1, Andrew J Thomas, MD, Richard Cannon, MD, Jason Hunt, MD, Luke Buchmann, MD, Dev Abraham, MD, Marcus M Monroe, MD, FACS, Mia Hashibe, PhD

University of Utah School of Medicine


D013

UTILITY OF PRE-OPERATIVE LOCALIZATION STUDIES IN DIAGNOSING THE INTRA-THYROIDAL PARATHYROID ADENOMA

Endocrine

Julia Noel, MD1, Ida Solis, MD2, Ramin Saket, MD3, Peter Shen, MD3, Mark Mamlouk, MD3, Ryan Niederkohr, MD3, Sumeer Gupta2, Lisa Orloff, MD1, Michael Friduss, MD3

1Stanford University, 2Kaiser Permanente San Francisco, 3Kaiser Permanente Santa Clara


D014

THE SURGICAL MANAGEMENT OF RETROPHARYNGEAL LYMPH NODE METASTASIS IN DIFFERENTIATED THYROID CARCINOMA

Endocrine

Victoria Harries, MBBS, Marlena McGill, BS, Laura Y Wang, MBBS, MS, Ashok R Shaha, MD, Jatin P Shah, MD, Richard J Wong, MD, R M Tuttle, MD, Snehal Patel, MD, Ian Ganly, MD, PhD

Memorial Sloan Kettering Cancer Center


D015

PREDICTIVE MODELING OF OPERATIVE TIME WITH TRANSORAL ENDOSCOPIC THYROIDECTOMY VESTIBULAR APPROACH (TOETVA)

Endocrine

Christopher R Razavi, MD, Lena W Chen, BA, Rohit Ranganath, MD, Ralph P Tufano, MD, MBA, Jonathon O Russell, MD

Johns Hopkins Department of OHNS


D016

LYMPH NODE RATIO AND OVERALL SURVIVAL IN PAPILLARY THYROID CANCER

Endocrine

Blaine D Smith, MD, Samantha M Thomas, MS, Taofik Oyekunle, MS, Daniel J Rocke, MD, JD

Duke University Medical Center


D018

INVESTIGATING THE POTENTIAL ROLE OF ANTI-PD-L1 IMMUNOTHERAPY IN AGGRESSIVE PAPILLARY THYROID CARCINOMA

Endocrine

L Boven1, S Terhoeve1, A Gundale1, B Beatrous1, T Moore-Medlin1, J McLarty1, X Ma1, H Savage1, X Gu1, R Ranganath2, C Nathan1

1LSU Health, 2Johns Hopkins